Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | CD44 | P16070 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20110472 | 0.81 | L3MBTL1 (0.50) | CYP2A6CYP1A2ALDH1A1CD44SMN1; SMN2 | |
| SCHEMBL15855019 | 0.80 | LMNA (0.37) | HSP90AA1CYP2A6CYP1A2ALDH1A1CD44 | |
| SCHEMBL19412050 | 0.77 | MEN1 (0.38) | NFKB1CYP2A6CYP1A2ALDH1A1KDM4E | |
| SCHEMBL12200494 | 0.77 | CYP2A6 (0.50) | CYP2A6CYP1A2ALDH1A1KDM4EHPGD | |
| SCHEMBL4209540 | 0.77 | NUDT1 (0.41) | HSP90AA1CYP1A2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL12697515 | 0.76 | CYP1A2 (0.49) | HSP90AA1NFKB1CYP1A2ALDH1A1KDM4E | |
| SCHEMBL13312929 | 0.74 | CYP2A6 (0.36) | CYP2A6CYP1A2ALDH1A1CD44HTR7 | |
| SCHEMBL17118867 | 0.73 | NPC1 (0.44) | CYP1A2ALDH1A1KDM4ESMN1; SMN2MEN1 | |
| SCHEMBL22344835 | 0.73 | ALDH1A1 (0.39) | HSP90AA1NFKB1CYP1A2ALDH1A1KDM4E | |
| SCHEMBL8385680 | 0.73 | MEN1 (0.38) | NFKB1CYP2A6CYP1A2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | TERT, CYP1A1, NR2E3 | HSP90AA1 4702/4885NFKB1 1179/4885CYP2A6 970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.